Cambrex gets PharmaCore | Chemical & Engineering News
Volume 94 Issue 39 | p. 18 | Concentrates
Issue Date: October 3, 2016

Cambrex gets PharmaCore

Department: Business
Keywords: pharmaceutical chemicals, APIs
[+]Enlarge
Cambrex will get this 3,300-m2 facility in North Carolina.
Credit: Cambrex
A photo of PharmaCore’s facility in North Carolina.
 
Cambrex will get this 3,300-m2 facility in North Carolina.
Credit: Cambrex

The pharmaceutical chemical maker Cambrex will pay $25 million to acquire PharmaCore, a High Point, N.C.-based developer of small-molecule active pharmaceutical ingredients for clinical trials. PharmaCore has annual sales of $15 million to $17 million and employs nearly 40 chemists, most of whom hold Ph.D.s. Cambrex says the company will complement its large-scale manufacturing facilities in the U.S. and Europe.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment